…
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -5.94M | -29.55M | -101.89M | 45.03M | -377.35M |
| Net income | -9.52M | -29.10M | -100.12M | 44.38M | -375.11M |
| Selling general administrative | 117.95M | 125.46M | 131.43M | 106.10M | 98.69M |
| Selling and marketing expenses | 93.59M | 118.31M | 144.50M | 160.08M | 111.58M |
| Gross profit | 196.36M | 182.30M | 155.11M | 250.34M | 181.83M |
| Reconciled depreciation | 25.35M | 33.68M | 28.64M | 22.02M | 21.28M |
| Ebit | 13.39M | -19.14M | -88.24M | -24.28M | -36.64M |
| Ebitda | 38.74M | 10.34M | -53.56M | -16.75M | -88.19M |
| Depreciation and amortization | 25.35M | 29.48M | 34.67M | 7.53M | -51.55M |
| Non operating income net other | - | - | - | 82.70M | -328.93M |
| Operating income | -20.80M | -67.77M | -130.92M | -24.28M | -36.64M |
| Other operating expenses | 321.59M | 402.07M | 528.91M | 390.16M | 296.73M |
| Interest expense | 19.33M | 10.41M | 13.65M | 13.39M | 11.78M |
| Tax provision | 3.58M | -0.45M | -3.60M | 0.65M | -2.24M |
| Interest income | 8.95M | 16.64M | 23.17M | 9.18M | - |
| Net interest income | -10.37M | 6.23M | 9.52M | -4.22M | -11.78M |
| Income tax expense | 3.58M | -0.45M | -1.77M | 0.65M | -2.24M |
| Total revenue | 300.79M | 334.29M | 397.99M | 365.88M | 260.09M |
| Total operating expenses | 217.17M | 250.07M | 286.03M | 274.62M | 218.47M |
| Cost of revenue | 104.43M | 152.00M | 242.88M | 115.54M | 78.26M |
| Total other income expense net | 14.87M | 38.22M | 29.03M | 69.31M | -340.71M |
| Net income from continuing ops | -9.52M | -29.10M | -100.12M | 44.38M | -375.11M |
| Net income applicable to common shares | - | - | - | 44.38M | -375.11M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 499.80M | 685.68M | 929.11M | 1008.91M | 1218.81M |
| Intangible assets | 35.80M | 47.51M | 62.12M | 46.39M | 56.01M |
| Other current assets | 5.36M | 9.49M | 13.88M | 26.70M | 12.32M |
| Total liab | 438.70M | 633.88M | 869.72M | 837.43M | 916.51M |
| Total stockholder equity | 61.10M | 51.80M | 59.39M | 171.48M | 302.30M |
| Deferred long term liab | - | - | - | 2.01M | 3.56M |
| Other current liab | 40.41M | 19.31M | 62.88M | 37.01M | 3.71M |
| Common stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M |
| Capital stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M |
| Retained earnings | -517.50M | -507.96M | -478.87M | -374.33M | -418.71M |
| Other liab | - | - | - | 17.48M | 97.38M |
| Good will | 126.60M | 123.50M | 125.82M | 124.59M | 123.69M |
| Other assets | - | - | - | 15.01M | 7.04M |
| Cash | 232.70M | 370.06M | 523.02M | 568.20M | 901.89M |
| Total current liabilities | 186.30M | 68.15M | 115.01M | 73.11M | 76.44M |
| Current deferred revenue | - | 2.38M | 2.76M | 0.81M | 39.96M |
| Net debt | 146.00M | 198.09M | 229.26M | 183.59M | -171.97M |
| Short term debt | 129.09M | 5.15M | 4.60M | 4.96M | 3.71M |
| Short long term debt | 123.96M | - | - | - | - |
| Short long term debt total | 378.70M | 568.16M | 752.29M | 751.79M | 729.91M |
| Other stockholder equity | 579.96M | 566.71M | 541.28M | 550.32M | 722.25M |
| Property plant equipment | - | - | - | 33.82M | 31.18M |
| Total current assets | 309.50M | 477.12M | 698.25M | 789.10M | 1000.89M |
| Net tangible assets | - | - | - | 0.50M | 122.59M |
| Net receivables | 23.44M | 28.46M | 70.03M | 77.77M | 51.42M |
| Long term debt | 240.43M | 552.20M | 738.37M | 734.14M | 729.91M |
| Inventory | 48.00M | 69.11M | 91.32M | 116.43M | 35.26M |
| Accounts payable | 15.60M | 21.94M | 44.77M | 30.34M | 29.05M |
| Accumulated other comprehensive income | -1.40M | -6.95M | -3.04M | -4.53M | -1.26M |
| Common stock total equity | - | - | - | 0.01M | 0.02M |
| Retained earnings total equity | - | - | - | -374.33M | -418.71M |
| Non currrent assets other | 11.90M | 14.09M | 16.04M | 14.19M | 6.71M |
| Non current assets total | 190.30M | 208.56M | 230.86M | 219.81M | 217.91M |
| Capital lease obligations | 14.37M | 15.96M | 13.92M | 17.65M | 16.49M |
| Long term debt total | - | - | - | 734.14M | 729.91M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -6.79M | -31.51M | -18.87M | 0.78M |
| Change to liabilities | - | - | - | -1.55M | 34.71M |
| Total cashflows from investing activities | -5.16M | -6.79M | -31.51M | -18.87M | -37.73M |
| Net borrowings | -173.35M | -156.08M | 0.00M | - | 413.02M |
| Total cash from financing activities | -174.93M | -158.34M | -37.45M | -205.24M | 959.03M |
| Change to operating activities | - | - | - | -31.84M | 11.83M |
| Net income | -9.52M | -29.10M | -100.12M | 44.38M | -375.11M |
| Change in cash | -137.39M | -152.96M | -45.17M | -333.69M | 892.40M |
| Begin period cash flow | 370.06M | 523.02M | 568.20M | 901.89M | 9.49M |
| End period cash flow | 232.67M | 370.06M | 523.02M | 568.20M | 901.89M |
| Total cash from operating activities | 37.48M | 16.13M | 21.75M | -106.60M | -28.36M |
| Depreciation | 25.35M | 33.68M | 34.67M | 22.02M | 21.14M |
| Other cashflows from investing activities | -4.86M | -6.79M | -18.46M | -8.02M | -27.31M |
| Change to inventory | 15.79M | -10.50M | -22.62M | -82.10M | -9.44M |
| Change to account receivables | 5.16M | 20.80M | 16.52M | -32.02M | -31.01M |
| Sale purchase of stock | 0.00M | -1.96M | -32.40M | -160.00M | 188.38M |
| Other cashflows from financing activities | -1.57M | -0.30M | -5.05M | -45.74M | 1189.52M |
| Change to netincome | - | - | - | -42.36M | 292.97M |
| Capital expenditures | 5.16M | 6.79M | 13.05M | 17.39M | 15.62M |
| Change receivables | - | - | - | -32.02M | -31.01M |
| Cash flows other operating | - | - | - | -15.82M | 41.59M |
| Cash and cash equivalents changes | - | - | - | -330.71M | 892.94M |
| Change in working capital | 10.37M | -27.39M | 23.36M | -140.28M | -18.66M |
| Stock based compensation | 14.82M | 26.70M | 22.54M | 28.50M | 12.42M |
| Other non cash items | -5.76M | 16.00M | 42.37M | -59.42M | 335.62M |
| Free cash flow | 32.32M | 9.34M | 8.70M | -123.99M | -43.98M |
Sector: Consumer Defensive Industry: Household & Personal Products
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SKIN SkinHealth Systems Inc. |
5.36 51.79% |
15.71 | - | 106.38 | 0.30 | 1.64 | 0.87 | 9.70 |
| PG Procter & Gamble Company |
-1.70 1.02% |
165.40 | 23.58 | 22.62 | 4.07 | 7.24 | 4.40 | 16.08 |
| LRLCF L'Oréal S.A |
-25.50 5.05% |
479.50 | 41.14 | 34.25 | 6.52 | 8.59 | 6.67 | 27.76 |
| LRLCY L’Oreal Co ADR |
-1.19 1.17% |
100.37 | 32.44 | 25.64 | 5.16 | 6.03 | 4.79 | 19.51 |
| UL Unilever PLC ADR |
-1.71 2.53% |
66.00 | 21.53 | 16.39 | 2.66 | 7.29 | 2.77 | 12.45 |
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
3600 E. Burnett Street, Long Beach, CA, United States, 90815
800 603 4996
613
| Name | Title | Year Born |
|---|---|---|
| Mr. Brenton L. Saunders J.D. | Exec. Chairman | 1970 |
| Ms. Liyuan Woo | Chief Financial Officer | 1972 |
| Mr. Daniel Copell Watson | Exec. VP of Americas Sales | 1962 |
| Mr. Andrew Stanleick | Pres, CEO & Director | 1971 |
| Eduardo Rodriguez | Sr. Director of M&A and Investor Relations | NA |
| Mr. Paul Bokota | VP & Gen. Counsel | NA |
| Ms. Kellie Sears | Chief HR Officer | NA |
| Dr. Jwala Karnik M.D. | Exec. VP of Strategy & Partnership | NA |
| Mr. Benjamin C. Baum | Chief Experience Officer | 1973 |
| Mr. Mingo Ku | Pres of North Asia | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.